Formidable Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Formidable Asset Management’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,057	Closed	-$14.1K	–	377
2024 Q2	$14.1K	Sell	1,057 -50	-5%	-$1.49K	﹤0.01%	391
2024 Q1	$51.4K	Buy	1,107 +20	+2%	+$1.03K	0.01%	383
2023 Q4	$73.5K	Buy	1,087 +487	+81%	+$29.8K	0.02%	277
2023 Q3	$43.4K	Buy	600 +55	+10%	+$4.4K	0.01%	280
2023 Q2	$41K	Buy	545 +29	+6%	+$1.72K	0.01%	280
2023 Q1	$27K	Buy	516 +7	+1%	+$444	0.01%	301
2022 Q4	$34K	Hold	509	–	–	0.01%	306
2022 Q3	$56K	Buy	509 +1	+0.2%	+$119	0.01%	288
2022 Q2	$64K	Buy	508 +123	+32%	+$15K	0.01%	295
2022 Q1	$62K	Buy	+385	New	+$74.9K	0.01%	330
2021 Q4	–	Sell	-1,507	Closed	-$699K	–	327
2021 Q3	$699K	Buy	+1,507	New	+$734K	0.13%	151

Other funds holding DNA

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Formidable Asset Management's DNA Position: Q3 2024 in Review

Formidable Asset Management sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 1,057 shares — an estimated $14.1K sold.

Formidable Asset Management first reported a position in DNA in Q3 2021 and held it in 11 quarters. The position peaked at $699K in Q3 2021. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

Formidable Asset Management reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
Formidable Asset Management sold 1,057 Ginkgo Bioworks shares in Q3 2024, an estimated $14.1K.
Formidable Asset Management first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 11 quarters.
Formidable Asset Management's Ginkgo Bioworks position peaked at $699K in Q3 2021.
159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Formidable Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.